Showing results (141-150 of 629) with videos related to
Sort By:
Pageof 63
Revue Medicale De Liege|July 23, 2005
[Towards a tripple oral therapy in the pharmacological treatment of type 2 diabetes?]A J ScheenRevue Medicale De Liege|November 23, 2006
[The CHARISMA study: in search of the best antiplatelet strategy for cardiovascular prevention]A J ScheenRevue Medicale De Liege|May 27, 2010
[NAVIGATOR: A trial of prevention of cardiovascular complications and type 2 diabetes with valsartan and/or nateglinide]A J ScheenRevue Medicale De Liege|August 1, 2009
[International classification of various types of monoclonal antibodies]A J ScheenRevue Medicale De Liege|August 1, 2009
[New advances in therapeutic use of monoclonal antibodies]A J ScheenRevue Medicale De Liege|August 20, 2015
[PHARMACEUTICAL INDUSTRY AND PERSONALIZED MEDICINE: A PARADIGM SHIFT IN THE DEVELOPMENT OF NEW DRUGS]A J ScheenDiabetes & Metabolism|February 3, 2020
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trialsA J ScheenRevue Medicale De Liege|January 14, 2021
[Which place to be reserved to sulphonylureas and which precautions to be taken ?]A J ScheenDiabetes & Metabolism|August 22, 2018
Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studiesA J ScheenPageof 63